发明授权
- 专利标题: INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES
- 专利标题(中): 响应概率SUGGESTION细胞毒性T淋巴细胞
-
申请号: EP92917479.5申请日: 1992-07-24
-
公开(公告)号: EP0596032B2公开(公告)日: 2004-04-07
- 发明人: RAYCHAUDHURI, Syamal , RASTETTER, William, H.
- 申请人: IDEC PHARMACEUTICALS CORPORATION
- 申请人地址: 11011 Torreyana Road San Diego, CA 92121-1104 US
- 专利权人: IDEC PHARMACEUTICALS CORPORATION
- 当前专利权人: IDEC PHARMACEUTICALS CORPORATION
- 当前专利权人地址: 11011 Torreyana Road San Diego, CA 92121-1104 US
- 代理机构: Campbell, Patrick John Henry
- 优先权: US735069 19910725
- 国际公布: WO1993001831 19930204
- 主分类号: A61K39/00
- IPC分类号: A61K39/00
摘要:
A compsn. is new, and comprises an antigen (I), except an albumin, mixed with an antigen formulation (II) consisting of: a stabilising detergent; a micelle-forming agent; and a biodegradable and biocompatible oil. (II) is a stable oil-in-water emulsion. Also new is a method for inducing a cytotoxic T-lymphocyte response in a human or animal comprising administering (I) and (II), (II) lacking an immunostimulating peptide component. (I) may be antigenic portions of HIV gp120, malaria antigens, CS protein and Sprorozoite surface protein, influenza antigens, carcinoma P21, etc. (I) also may not include a B-cell lymphoma anitgen.
公开/授权文献
- EP0596032B1 INDUCTION OF CYTOTOXIC T-LYMPHOCYTE RESPONSES 公开/授权日:1998-05-27
信息查询